The results of the clinical trials of the various products and solutions in development will of course be followed closely by investors. In the medium term, we should learn a little more about the trial phases of ViaskinPT against pertussis and the market launch of Viaskin Peanut.
The DBV Technologies share price is currently listed on the French stock exchange, i.e. on the Euronext Paris stock exchange. It is also important to note that this company is also part of the composition of various stock market indices, including of course the SBF 120, but also other indices such as the CAC Mid 60, the CAC All sgares, the Cac All tradable, the CAC Mid Small, the CAC PME, Enternext, Next 150, Next Biotech and others.